Skip to main content
OpenTrials

Clinical trial condition

Lung Cancer (NSCLC)

Explore clinical trials studying Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

98 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Lung Cancer (NSCLC) trial results

Completed

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

NCT02552121

Conditions
Adnexal Diseases, Bladder Cancer, Bronchial Neoplasms, +48 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • Institut Jules Bordet Brussels, Brussels Capital, Belgium
  • Universitaire Ziekenhuizen Leuven Leuven, Flemish Brabant, Belgium
  • Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium
View all 16 locations
View Trial Details
Completed

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin

NCT02279732

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Chongqing, Chongqing Municipality, China
  • Local Institution Fuzhou, Fujian, China
View all 49 locations
View Trial Details
Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions
Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Salinas Valley Memorial Healthcare System Salinas, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Memorial Health System Pembroke Pines, Florida, United States
View Trial Details

Related conditions